Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Egetis Therapeutics AB (publ) (ST: EGTX)

 
EGTX Technical Analysis
4
As on 14th Jan 2025 EGTX STOCK Price closed @ 5.89 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.68 & Strong Buy for SHORT-TERM with Stoploss of 4.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

EGTXSTOCK Price

Open 5.94 Change Price %
High 6.10 1 Day -0.01 -0.17
Low 5.83 1 Week -1.21 -17.04
Close 5.89 1 Month 0.25 4.43
Volume 423834 1 Year 1.58 36.66
52 Week High 9.18 | 52 Week Low 3.91
 
ST Sweden Most Active Stocks
FING-B 0.04 0.00%
QLINEA 0.50 284.62%
HDW-B 0.00 %
LIPI 0.25 -7.41%
SBB-B 4.91 0.61%
LUNE 21.97 6.65%
WYLD 0.01 0.00%
ENERS 0.00 %
KLAR 0.61 -8.96%
NIBE-B 38.72 -2.64%
 
ST Sweden Top Gainers Stocks
NFGAB 13.50 10284.62%
QLINEA 0.50 284.62%
KOPY 0.10 150.00%
SPIFF 0.04 33.33%
QLIFE 2.12 32.50%
HELIO 0.44 25.71%
ONCOZ 5.00 22.55%
PCOM-B 0.94 14.63%
BOUL 9.96 13.96%
CE 0.17 13.33%
 
ST Sweden Top Losers Stocks
NGENIC 0.43 -56.57%
ZICC 0.25 -34.21%
ALLR 1.55 -26.54%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
TESSIN 0.13 -18.75%
PHARM 0.56 -16.42%
PHARM 0.56 -16.42%
LIDDS 0.13 -13.33%
 
 
EGTX
Daily Charts		 EGTX
Intraday Charts		 Whats New @
Bazaartrend		 EGTX
Free Analysis
 
EGTX Important Levels Intraday
RESISTANCE6.41
RESISTANCE6.24
RESISTANCE6.14
RESISTANCE6.04
SUPPORT5.74
SUPPORT5.64
SUPPORT5.54
SUPPORT5.37
 
EGTX Forecast January 2025
Share
4th UP Forecast7.68
3rd UP Forecast7.11
2nd UP Forecast6.75
1st UP Forecast6.4
1st DOWN Forecast5.38
2nd DOWN Forecast5.03
3rd DOWN Forecast4.67
4th DOWN Forecast4.1
 
EGTX Weekly Forecast
4th UP Forecast7.20
3rd UP Forecast6.78
2nd UP Forecast6.52
1st UP Forecast6.26
1st DOWN Forecast5.52
2nd DOWN Forecast5.26
3rd DOWN Forecast5.00
4th DOWN Forecast4.58
 
EGTX Forecast2025
4th UP Forecast16.43
3rd UP Forecast13.05
2nd UP Forecast10.96
1st UP Forecast8.87
1st DOWN Forecast2.91
2nd DOWN Forecast0.82
3rd DOWN Forecast-1.27
4th DOWN Forecast-4.65
 
 
EGTX Other Details
Segment EQ
Market Capital 949146688.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
EGTX Address
EGTX
 
EGTX Latest News
 
Your Comments and Response on Egetis Therapeutics AB (publ)
 
EGTX Business Profile
Egetis Therapeutics AB (publ), a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment. Its products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of MCT8 deficiency, a rare inborn error of thyroid hormone signaling that is in phase IIb/III clinical trial. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was founded in 2006 and is based in Stockholm, Sweden. Address: Grev Turegatan 11c, Stockholm, Sweden, 114 46
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service